Gossamer Bio (GOSS) news
Recent news
CPBIO renewal of continuing connected transactions, notice of special general meeting
Cancer Prevention & Biotechnology Limited (CPBIO) has announced the renewal of its continuing connected transactions, as disclosed in a recent regulatory filing. The company has also issued a notice of a special general meeting (SGM) to be held on October 30, 2026, for shareholders to consider and…
AInvest Wire · 1d agoCPBIO renewal of continuing connected transactions, notice of special general meeting
AInvest Wire · 1d agoGossamer Bio initiated buy at Chardan, PT $160
AInvest Wire · 2d agoGossamer Bio, Inc.: H.C. Wainwright adjusts target price to $90 to reflect 1-for-80 reverse stock split
H.C. Wainwright has adjusted its price target for Gossamer Bio, Inc. (GOSS) to $90, reflecting the company’s 1-for-80 reverse stock split . This adjustment follows a strategic capital structure modification approved by stockholders on July 14, 2026, which significantly reduced the company’s debt…
AInvest Wire · Sep 21, 2026Gossamer Bio appoints Greg Ciongoli to board of directors
Gossamer Bio, Inc. (NASDAQ: GOSL) has announced the appointment of Greg Ciongoli to its board of directors, effective September 15, 2026. Ciongoli brings extensive experience in biotechnology and pharmaceutical leadership, having previously served in executive roles at several life sciences…
AInvest Wire · Sep 16, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.